Related Experiment Video
Updated: May 31, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
TP53 mutations in human cancer: database reassessment and prospects for the next decade
1Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institute, Stockholm, Sweden.
Abstract:
TP53 mutations are the most frequent genetic alterations found in human cancer. For more than 20 years, TP53 mutation databases have collected over 30,000 somatic mutations from various types of cancer. Analyses of these mutations have led to many types of studies and have improved our knowledge about the TP53 protein and its function. The recent advances in sequencing methodologies and the various cancer genome sequencing projects will lead to a profound shift in database curation and data management. In this paper, we will review the current status of the TP53 mutation database, its application to various fields of research, and how data quality and curation can be improved. We will also discuss how the genetic data will be stored and handled in the future and the consequences for database management.
Insights
TP53 mutation databases track over 30,000 cancer mutations, aiding research. Future advancements will significantly impact TP53 database curation and data management strategies.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- TP53 mutations are the most common genetic alterations in human cancers.
- TP53 mutation databases have accumulated over 30,000 somatic mutations from diverse cancer types.
- Extensive analysis of these mutations has enhanced understanding of the TP53 protein and its functions.
Purpose of the Study:
- To review the current state of the TP53 mutation database.
- To discuss the applications of TP53 mutation data in various research fields.
- To explore improvements in data quality and curation for TP53 databases.
Main Methods:
- Review of existing TP53 mutation databases.
- Analysis of the impact of recent sequencing technologies and cancer genome projects.
- Discussion of future data storage, handling, and management strategies.
Main Results:
- TP53 mutation databases are valuable resources for cancer research.
- Advances in sequencing necessitate updates in database curation and management.
- Improved data quality and curation are crucial for future research.
Conclusions:
- The TP53 mutation database is a critical resource in cancer genetics.
- Future database management must adapt to new sequencing technologies and large-scale data.
- Enhanced data quality and curation will maximize the utility of TP53 mutation data for advancing cancer research.
More Related Videos
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation

